Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
21,96 USD | +0,64% | +1,81% | +500,00% |
01/04 | LANDOS BIOPHARMA, INC. : HC Wainwright verlaagt advies naar Neutraal | ZM |
25/03 | Deals van de dag - Fusies en overnames | RE |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 68,44 mln. 64,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -26 mln. -24,36 mln. | Nettowinst (verlies) 2025 * | -46 mln. -43,09 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 72,5 mln. 67,92 mln. | Nettoliquiditeiten 2025 * | 30 mln. 28,1 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-9,34
x | K/w-verhouding 2025 * |
-13
x | Werknemers | 19 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 42,42% |
1 dag | +0,64% | ||
1 week | +1,81% | ||
Lopende maand | +2,23% | ||
1 maand | +180,46% | ||
3 maanden | +352,78% | ||
6 maanden | +500,00% | ||
Lopend jaar | +500,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Oakes
CEO | Chief Executive Officer | 56 | 21-06-22 |
Claudia Lopez
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Dawn Louro
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 57 | 01-09-17 | |
Tim Mayleben
BRD | Director/Board Member | 63 | 13-05-21 |
Alka Batycky
BRD | Director/Board Member | 54 | 30-05-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 21,96 | +0,64% | 13 185 |
19-04-24 | 21,82 | +0,32% | 14 687 |
18-04-24 | 21,75 | +0,37% | 20 783 |
17-04-24 | 21,67 | +0,70% | 15 314 |
16-04-24 | 21,52 | -0,23% | 19 143 |
uitgestelde koers Nasdaq, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+500,00% | 68,44 mln. | |
-0,02% | 42,11 mld. | |
+48,77% | 40,08 mld. | |
+5,04% | 40 mld. | |
-11,32% | 26,87 mld. | |
+5,25% | 24,58 mld. | |
-23,83% | 18,44 mld. | |
-1,62% | 11,94 mld. | |
+22,75% | 11,66 mld. | |
+6,44% | 11,01 mld. |